Sun Pharma to acquire Organon for $14 per share in $11.75 billion deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
BNP Paribas Exane Downgrades Organon & Co. (OGN) to Neutral Post Acquisition
April 28, 2026 6:17 AM EDTBNP Paribas Exane analyst Navaan Ty downgraded Organon & Co. (NYSE: OGN) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.
Shares of Organon & Co. closed at $13.16 yesterday.
... More